OKYO Pharma (OKYO) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 3, 2023 (07:56)
Sector: HealthcareThe share price of OKYO Pharma Limited (OKYO) now
50/200 Day Moving Average: $1.786 / $1.679
This figure corresponds to the Average Price over the previous 50/200 days. For OKYO Pharma stocks, the 50-day moving average is the resistance level today.
For OKYO Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in OKYO Pharma Limited stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the OKYO Pharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one OKYO Pharma share be worth in 2024 - 2028?
When should I take profit in OKYO Pharma stock? When should I record a loss on OKYO Pharma stock? What are analysts' forecasts for OKYO Pharma stock? What is the future of OKYO Pharma stock? We forecast OKYO Pharma stock performance using neural networks based on historical data on OKYO Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
OKYO Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for OKYO Pharma shares. This happens once a day.
Historical and forecast chart of OKYO Pharma stock
The chart below shows the historical price of OKYO Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the OKYO Pharma stock price can be found in the table below.
Long-term forecasts by years.
OKYO Pharma Limited operates as a preclinical biopharmaceutical company in the United Kingdom. Its preclinical development program includes OK-101 for the treatment of dry eyes, uveitis, and allergic conjunctivitis; and OK-201 to treat corneal neuropathic pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome (ARDS). OKYO Pharma Limited was incorporated in 2018 and is headquartered in London, the United Kingdom.
OKYO Pharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 05 | 1.60 | 1.50 | 1.67 | 10.74 |
| Dec 06 | 1.64 | 1.53 | 1.68 | 9.41 |
| Dec 07 | 1.49 | 1.43 | 1.58 | 10.43 |
| Dec 08 | 1.35 | 1.27 | 1.38 | 9.00 |
| Dec 09 | 1.45 | 1.41 | 1.51 | 7.22 |
| Dec 10 | 1.46 | 1.43 | 1.56 | 9.29 |
| Dec 11 | 1.47 | 1.41 | 1.59 | 12.40 |
| Dec 12 | 1.55 | 1.43 | 1.62 | 13.67 |
| Dec 13 | 1.68 | 1.59 | 1.81 | 13.62 |
| Dec 14 | 1.64 | 1.54 | 1.72 | 11.62 |
| Dec 15 | 1.70 | 1.66 | 1.83 | 10.59 |
| Dec 16 | 1.67 | 1.55 | 1.74 | 12.23 |
| Dec 17 | 1.69 | 1.62 | 1.78 | 10.26 |
| Dec 18 | 1.63 | 1.55 | 1.67 | 7.57 |
| Dec 19 | 1.67 | 1.58 | 1.74 | 10.14 |
| Dec 20 | 1.77 | 1.65 | 1.83 | 10.60 |
| Dec 21 | 1.86 | 1.81 | 1.93 | 6.15 |
| Dec 22 | 2.03 | 1.95 | 2.11 | 8.00 |
| Dec 23 | 1.93 | 1.82 | 2.06 | 13.23 |
| Dec 24 | 1.88 | 1.80 | 1.92 | 6.45 |
| Dec 25 | 1.84 | 1.77 | 1.97 | 11.53 |
| Dec 26 | 1.79 | 1.71 | 1.92 | 11.91 |
| Dec 27 | 1.85 | 1.74 | 1.93 | 10.93 |
| Dec 28 | 2.00 | 1.88 | 2.10 | 11.80 |
| Dec 29 | 2.05 | 1.92 | 2.19 | 14.09 |
| Dec 30 | 2.17 | 2.08 | 2.27 | 8.96 |
| Dec 31 | 2.21 | 2.09 | 2.35 | 12.04 |
| Jan 01 | 2.30 | 2.21 | 2.47 | 11.98 |
| Jan 02 | 2.15 | 2.09 | 2.28 | 9.16 |
| Jan 03 | 1.96 | 1.86 | 2.04 | 9.46 |
OKYO Pharma Daily Price Targets
OKYO Pharma Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $1.60.
Negative dynamics for OKYO Pharma shares will prevail with possible volatility of 9.702%.
Pessimistic target level: 1.50
Optimistic target level: 1.67
OKYO Pharma Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $1.64.
Positive dynamics for OKYO Pharma shares will prevail with possible volatility of 8.602%.
Pessimistic target level: 1.53
Optimistic target level: 1.68
OKYO Pharma Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $1.49.
Negative dynamics for OKYO Pharma shares will prevail with possible volatility of 9.443%.
Pessimistic target level: 1.43
Optimistic target level: 1.58
OKYO Pharma Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $1.35.
Negative dynamics for OKYO Pharma shares will prevail with possible volatility of 8.260%.
Pessimistic target level: 1.27
Optimistic target level: 1.38
OKYO Pharma Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $1.45.
Positive dynamics for OKYO Pharma shares will prevail with possible volatility of 6.737%.
Pessimistic target level: 1.41
Optimistic target level: 1.51
OKYO Pharma Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $1.46.
Positive dynamics for OKYO Pharma shares will prevail with possible volatility of 8.497%.
Pessimistic target level: 1.43
Optimistic target level: 1.56
OKYO (OKYO) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan. | 2.04 | 1.68 | 2.27 | 26.07 |
| Feb. | 1.84 | 1.48 | 2.16 | 31.49 |
| Mar. | 1.89 | 1.69 | 2.13 | 20.49 |
| Apr. | 1.43 | 1.32 | 1.60 | 17.63 |
| May. | 1.48 | 1.23 | 1.59 | 22.61 |
| Jun. | 1.41 | 1.14 | 1.51 | 24.42 |
| Jul. | 1.72 | 1.43 | 1.87 | 23.62 |
| Aug. | 1.69 | 1.57 | 1.82 | 13.95 |
| Sep. | 1.64 | 1.54 | 1.73 | 10.69 |
| Oct. | 1.58 | 1.33 | 1.79 | 25.77 |
| Nov. | 1.76 | 1.47 | 1.99 | 26.05 |
| Dec. | 1.93 | 1.78 | 2.11 | 15.95 |
OKYO Pharma forecast for this year
OKYO Pharma Stock Prediction for Jan 2024
An uptrend is forecast for this month with an optimal target price of $2.0375. Pessimistic: $1.68. Optimistic: $2.27
OKYO Pharma Stock Prediction for Feb 2024
An downtrend is forecast for this month with an optimal target price of $1.83884. Pessimistic: $1.48. Optimistic: $2.16
OKYO Pharma Stock Prediction for Mar 2024
An uptrend is forecast for this month with an optimal target price of $1.89401. Pessimistic: $1.69. Optimistic: $2.13
OKYO Pharma Stock Prediction for Apr 2024
An downtrend is forecast for this month with an optimal target price of $1.42998. Pessimistic: $1.32. Optimistic: $1.60
OKYO Pharma Stock Prediction for May 2024
An uptrend is forecast for this month with an optimal target price of $1.48003. Pessimistic: $1.23. Optimistic: $1.59
OKYO Pharma Stock Prediction for Jun 2024
An downtrend is forecast for this month with an optimal target price of $1.40602. Pessimistic: $1.14. Optimistic: $1.51
OKYO Pharma Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $1.71535. Pessimistic: $1.43. Optimistic: $1.87
OKYO Pharma Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $1.69391. Pessimistic: $1.57. Optimistic: $1.82
OKYO Pharma Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $1.64309. Pessimistic: $1.54. Optimistic: $1.73
OKYO Pharma Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $1.58148. Pessimistic: $1.33. Optimistic: $1.79
OKYO Pharma Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $1.75939. Pessimistic: $1.47. Optimistic: $1.99
OKYO Pharma Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $1.92653. Pessimistic: $1.78. Optimistic: $2.11
OKYO Pharma (OKYO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.86 | 1.77 | 2.01 | 12.04 |
| Feb | 2.06 | 1.93 | 2.36 | 18.12 |
| Mar | 2.54 | 2.03 | 2.88 | 29.36 |
| Apr | 3.10 | 2.79 | 3.72 | 25.05 |
| May | 2.98 | 2.58 | 3.28 | 21.32 |
| Jun | 3.06 | 2.87 | 3.31 | 13.19 |
| Jul | 3.77 | 3.54 | 4.22 | 16.07 |
| Aug | 3.79 | 3.38 | 4.21 | 19.82 |
| Sep | 3.75 | 3.34 | 4.29 | 22.05 |
| Oct | 3.61 | 3.42 | 4.28 | 20.21 |
| Nov | 3.06 | 2.82 | 3.58 | 21.20 |
| Dec | 3.39 | 3.11 | 3.98 | 21.91 |
OKYO Pharma (OKYO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.07 | 3.68 | 4.30 | 14.45 |
| Feb | 4.75 | 4.39 | 5.67 | 22.64 |
| Mar | 4.81 | 4.24 | 5.30 | 20.00 |
| Apr | 4.46 | 3.79 | 4.88 | 22.20 |
| May | 4.82 | 4.07 | 5.06 | 19.52 |
| Jun | 4.79 | 4.46 | 5.71 | 21.80 |
| Jul | 4.49 | 3.84 | 5.38 | 28.75 |
| Aug | 4.73 | 4.13 | 5.21 | 20.68 |
| Sep | 5.35 | 4.59 | 5.94 | 22.75 |
| Oct | 6.58 | 6.22 | 6.92 | 10.21 |
| Nov | 6.46 | 5.98 | 7.16 | 16.48 |
| Dec | 6.74 | 6.35 | 7.13 | 10.87 |
OKYO Pharma (OKYO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.28 | 6.70 | 7.88 | 15.01 |
| Feb | 7.97 | 6.69 | 8.69 | 22.94 |
| Mar | 6.97 | 6.19 | 8.09 | 23.49 |
| Apr | 7.18 | 6.03 | 8.31 | 27.43 |
| May | 6.34 | 5.86 | 6.67 | 12.11 |
| Jun | 5.55 | 4.71 | 6.49 | 27.35 |
| Jul | 4.85 | 3.97 | 5.41 | 26.68 |
| Aug | 5.54 | 4.98 | 6.63 | 24.90 |
| Sep | 5.64 | 4.57 | 6.01 | 23.94 |
| Oct | 6.70 | 5.59 | 7.15 | 21.78 |
| Nov | 7.08 | 6.55 | 7.70 | 14.94 |
| Dec | 6.71 | 5.72 | 7.92 | 27.75 |
OKYO Pharma (OKYO) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.28 | 5.99 | 8.03 | 25.40 |
| Feb | 8.27 | 7.83 | 8.89 | 11.86 |
| Mar | 7.71 | 6.36 | 8.63 | 26.34 |
| Apr | 7.13 | 6.43 | 8.50 | 24.32 |
| May | 6.43 | 6.11 | 6.90 | 11.42 |
| Jun | 4.92 | 4.00 | 5.35 | 25.29 |
| Jul | 4.44 | 3.98 | 5.10 | 22.00 |
| Aug | 4.01 | 3.59 | 4.80 | 25.26 |
| Sep | 4.66 | 3.97 | 4.92 | 19.19 |
| Oct | 5.34 | 4.36 | 5.90 | 26.02 |
| Nov | 6.19 | 5.65 | 6.59 | 14.32 |
| Dec | 5.97 | 4.78 | 6.80 | 29.67 |
OKYO Pharma information and performance
55 PARK LANE, LONDON, GB
Market capitalization of the OKYO Pharma Limited is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of OKYO shares in the company outstanding by the market price of one share.
EBITDA of OKYO Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
